Women's Health

Trial meets its primary endpoint of progression-free survival regardless of mismatch repair status in patients with stage 3 or 4 or recurrent endometrial carcinoma.

By binding to and inhibiting RANKL, denosumab decreases the production and activity of osteoclasts, resulting in reduced bone loss.

Earlier this week, the FDA Oncologic Drugs Advisory Committee also voted 8 to 5 in support of data for dostarlimab-gxly in rectal cancer.

Multiple adverse outcomes were associated with an even higher risk of heart disease.

JNJ-80202135 (nipocalimab) treats hemolytic disease of the fetus and newborn caused by maternal red blood cells.

Vitamin D supplementation is a vital and inexpensive way to prevent and treat deficiency; however, its use in preventing and treating other conditions is less clear.

Migraine could be considered a clinical marker of increased obstetric risk in pregnant women.

Viral vector vaccines and a booster can protect maternal women against the Omicron variant of COVID-19, but the mRNA vaccine with a booster dose appears to offer the best protection.

Patients who received the interventions reported improved anxiety and pain levels.

Antibodies help neutralize the virus, though the levels decrease at the 6-month mark, data indicate.

Although the FDA has now allowed retail pharmacies to dispense mifepristone, a drug used for medicated abortions, questions still remain about the requirements for pharmacies and the availability of the drug.

Mothers, in particular, benefit when they are given longer leaves and policies that offer incentives or wage replacement, analysis indicates.

Pharmacists are ideally positioned within communities to identify patients struggling with perinatal depression.

Following the positive phase 3 results, GSK anticipates regulatory submissions in the first half of 2023.

Based on the ALIFE 2 trial results, the investigators do not advise the routine use of low-molecular-weight heparin in women with recurrent pregnancy loss and confirmed inherited thrombophilia.

Zuranolone is a rapid-acting, once-daily, 14-day oral short course therapy for adult patients with major depressive disorder and postpartum depression.

Nearly half of the study population received a first-time hypertension diagnosis post hospitalization, with approximately half of these new cases occurring more than 6 weeks postpartum.

A survey of women in New York confirmed that nearly three-quarters would be comfortable getting a contraceptive prescription from a pharmacist.

Prior research has associated early adolescent use of hormonal contraceptives with the risk of depression in adulthood.

Educating patients while remaining empathetic, sharing personal experiences helps overcome this hurdle.

Mild preeclampsia and late-developing preeclampsia were not found to increase risk of stroke as much as early-stage.

In addition to the ongoing COVID-19 pandemic, significant public health concerns include opioid overdoses, maternal mortality disparities, and climate change.

Systemically administered hormonal therapy may be associated with a greater risk of depression before and during menopause.

Pre-planned safety reviews performed for the duration of the study found that the investigational vaccine is well-tolerated with no safety concerns for both the vaccinated individuals and their newborns.

Chronic hypertension during pregnancy increases the risk of poor pregnancy and birth outcomes.

Investigators examined the impact of daily oral tenofovir disoproxil fumarate in combination with emtricitabine to see the effect on the microbiota in South African women.

Investigators found that lifestyle changes such as a high-quality diet and regular exercise can lower the risk of type 2 diabetes in women with a history of gestational diabetes mellitus.

Nakia Eldridge, PharmD, MBA, discussed her career, the impacts of COVID-19 on women in pharmacy, and how mentorship can pave the way for more women pharmacists.

This year marks the fifth annual Women Pharmacist Day after it was founded in 2018.

Suzanne Soliman, PharmD, BCMAS, discusses how she will be celebrating the important contributions of women pharmacists.